Pitavastatin Calcium/Valsartan

匹伐他汀钙/缬沙坦

Report date: 2026/01/15 20:00:17

Base Information

Drug NamePitavastatin Calcium/Valsartan
Drug Alias NameValsartan/pitavastatin缬沙坦/匹伐他汀钙Pitavastatin/valsartanLivasartanLivaloV +[6] 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Pitavastatin CalciumValsartan
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJw Pharmaceutical Corp
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A